Translation of "Plasma substitute" in German

Polyvinylpyrrolidone solutions are already used extensively as plasma substitute.

For instance, the thrombocyte concentration in blood should be determined, and the preparation of the blood sample essentially resides in either diluting the blood in an isotonic plasma replacement or substitute solution in a ratio of 1:80,000 or centrifuging the blood and diluting the residually obtained plasma in an isotonic plasma replacement solution in a ratio of 1:2200.

A 1% strength solution of human albumin or plasma substitute HaemaccelR (manufacturer: Behringwerke AG, 3500 Marburg, Federal Republic of Germany) containing 0.01% of thiomersal in 0.85N NaCl solution is used for the dilution.

The corpuscular constituents, after total or partial volume replacement of the withdrawn plasma, are resuspended in the plasma substitute and reinfused into the patient.

PVP was initially used as a blood plasma substitute and later in a wide variety of applications in medicine, pharmacy, cosmetics and industrial production.

The addition of electrolyte solutions or salt solutions is advisable if it is desired to regulate or modify the osmotic pressure of the plasma substitute.

Since this additional protein should preferably have no pharmacological activity at all and should not stimulate the production of antibodies either, human serum albumin (HSA) is currently used for these purposes, which furthermore may be obtained at low prices, as it is applied in high amounts as plasma substitute.

If on the other hand a polymer comprising only molecules of low molecular weight--to ensure good excretion via the kidneys--is used as the plasma substitute, the colloidal osmotic pressure, and hence the effectiveness of the substitute, is low.

If on the other hand a polymer consisting only of molecules of relatively low molecular weight is used as the plasma substitute, to ensure efficient elimination through the kidneys, the colloid-osmotic pressure, and hence the activity, are low.

In severe cases, plasma-substituting saline solutions are administered intravenously.

The novel block polymers have the same effect as the polyvinylpyrrolidones conventionally used as plasma substitutes.

For this purpose, plasma substitutes are used and a 0.9% sodium chloride solution is administered by the intravenous route.

If there is no fluid in the lungs, plasma-substituting compounds can be administered intravenously.

The drug, like other plasma-substituting drugs, is intended for use in hospital settings.

For first aid in cases of physiological shock, it is frequently necessary to use plasma substitutes, since blood stocks are in most cases not immediately available.

For the collection, storage and administration of parenteral liquids such as blood, blood plasma, blood substitutes, infusion solutions and other physiological liquids containers made from plasticizer-containing polyvinyl chloride are used.

To prepare plasma substitutes, the conventional methods for preparing pyrogen-free fluids can be employed, and physiological sodium chloride solution or Ringer's solution can also be admixed.

A synthetic blood that takes over completely the role of the natural fluid must, however, be capable of reversibly fixing and conveying oxygen and carbon dioxide, which polyvinylpyrrolidone (or the other plasma substitutes which have been developed), are unable to do.

The polymers polyvinylamine, polyvinyl methyl ether, polyvinylpyrrolidone and their copolymers are used, for example, for adhesives, eye drops, and blood plasma substitutes.

The separated blood plasma is purified or replaced with a substitution solution, and the purified blood plasma or the substitution solution is returned to the patient.